DK0506463T3 - Hidtil ukendte forbindelser betegnet leustroducsiner, deres fremstilling og deres terapeutiske anvendelser - Google Patents

Hidtil ukendte forbindelser betegnet leustroducsiner, deres fremstilling og deres terapeutiske anvendelser

Info

Publication number
DK0506463T3
DK0506463T3 DK92302718.9T DK92302718T DK0506463T3 DK 0506463 T3 DK0506463 T3 DK 0506463T3 DK 92302718 T DK92302718 T DK 92302718T DK 0506463 T3 DK0506463 T3 DK 0506463T3
Authority
DK
Denmark
Prior art keywords
leustroducsins
new compounds
termed
preparation
therapeutic uses
Prior art date
Application number
DK92302718.9T
Other languages
Danish (da)
English (en)
Inventor
Takafumi Komaha
Isao Kaneko
Takemichi Nakamura
Keiichi Matsuda
Takeshi Kagasaki
Ryuzo Enokita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK0506463T3 publication Critical patent/DK0506463T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/903Streptomyces platensis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK92302718.9T 1991-03-27 1992-03-27 Hidtil ukendte forbindelser betegnet leustroducsiner, deres fremstilling og deres terapeutiske anvendelser DK0506463T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6308791 1991-03-27

Publications (1)

Publication Number Publication Date
DK0506463T3 true DK0506463T3 (da) 1996-06-10

Family

ID=13219198

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92302718.9T DK0506463T3 (da) 1991-03-27 1992-03-27 Hidtil ukendte forbindelser betegnet leustroducsiner, deres fremstilling og deres terapeutiske anvendelser

Country Status (23)

Country Link
US (2) US5334587A (hu)
EP (1) EP0506463B1 (hu)
JP (1) JPH05123179A (hu)
KR (1) KR0145680B1 (hu)
CN (1) CN1058294C (hu)
AT (1) ATE134640T1 (hu)
AU (1) AU649116B2 (hu)
CA (1) CA2064126A1 (hu)
CZ (1) CZ279299B6 (hu)
DE (1) DE69208494T2 (hu)
DK (1) DK0506463T3 (hu)
ES (1) ES2086651T3 (hu)
FI (1) FI101978B (hu)
GR (1) GR3019996T3 (hu)
HK (1) HK117696A (hu)
HU (1) HU216875B (hu)
IE (1) IE74389B1 (hu)
IL (1) IL101394A (hu)
IS (1) IS1604B (hu)
NO (1) NO304600B1 (hu)
NZ (1) NZ242155A (hu)
RU (1) RU2082760C1 (hu)
TW (1) TW212182B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU649116B2 (en) * 1991-03-27 1994-05-12 Sankyo Company Limited New compounds, named the "Leustroducins", their preparation and their therapeutic uses
ATE166058T1 (de) * 1993-04-23 1998-05-15 Sankyo Co Neue verbindung, leustroducsin h, ihre herstellung und therapeutische verwendung
WO1997014704A1 (fr) * 1995-10-17 1997-04-24 Suntory Limited Medicament contre la thrombopenie
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
JP2007519609A (ja) * 2003-09-17 2007-07-19 アイコス コーポレイション 細胞増殖を制御するためのchk1インヒビターの使用
US9005242B2 (en) 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
US8956389B2 (en) 2009-06-22 2015-02-17 W. L. Gore & Associates, Inc. Sealing device and delivery system
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
CN113262293B (zh) * 2020-02-17 2022-11-08 中国医学科学院医药生物技术研究所 一组具有抗病毒活性的肽类化合物奥米克欣及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592925A (en) * 1969-04-21 1971-07-13 American Cyanamid Co Antibiotics ah272alpha2 and ah272beta2 and process for producing same
US3907779A (en) * 1974-05-20 1975-09-23 Upjohn Co 5,6 Dihydro-5-azathymidine and derivatives
AU574713B2 (en) * 1983-09-12 1988-07-14 Warner-Lambert Company Cl-1957a antibiotic compound and its production
US4575500A (en) * 1984-03-26 1986-03-11 Merck & Co., Inc. Antifungal substances and process for their production
JPH02186A (ja) * 1987-05-07 1990-01-05 Sumitomo Chem Co Ltd 新規化合物およびそれを有効成分とする農工業用殺菌剤
EP0329361B1 (en) * 1988-02-13 1995-12-06 Suntory Limited 2-pyranone derivatives and process for production thereof
JP2865302B2 (ja) * 1988-02-13 1999-03-08 サントリー株式会社 2―ピラノン誘導体及びその製造法並びにそれを含む抗菌剤
AU649116B2 (en) * 1991-03-27 1994-05-12 Sankyo Company Limited New compounds, named the "Leustroducins", their preparation and their therapeutic uses

Also Published As

Publication number Publication date
JPH05123179A (ja) 1993-05-21
ATE134640T1 (de) 1996-03-15
RU2082760C1 (ru) 1997-06-27
IE74389B1 (en) 1997-07-30
TW212182B (hu) 1993-09-01
IL101394A (en) 1996-05-14
CN1058294C (zh) 2000-11-08
FI101978B1 (fi) 1998-09-30
IE920965A1 (en) 1992-10-07
FI921339A (fi) 1992-09-28
CN1066292A (zh) 1992-11-18
ES2086651T3 (es) 1996-07-01
EP0506463B1 (en) 1996-02-28
EP0506463A3 (en) 1993-01-13
AU649116B2 (en) 1994-05-12
FI101978B (fi) 1998-09-30
AU1312392A (en) 1992-10-01
US5334587A (en) 1994-08-02
FI921339A0 (fi) 1992-03-26
KR0145680B1 (ko) 1998-08-01
KR920018215A (ko) 1992-10-21
IS3829A (is) 1992-09-28
HK117696A (en) 1996-07-12
IL101394A0 (en) 1992-11-15
CA2064126A1 (en) 1992-09-28
HUT60521A (en) 1992-09-28
DE69208494T2 (de) 1996-10-24
NZ242155A (en) 1993-09-27
CZ279299B6 (cs) 1995-04-12
EP0506463A2 (en) 1992-09-30
GR3019996T3 (en) 1996-08-31
DE69208494D1 (de) 1996-04-04
HU9201005D0 (en) 1992-06-29
US5443972A (en) 1995-08-22
IS1604B (is) 1996-10-18
NO921158D0 (no) 1992-03-25
HU216875B (hu) 1999-09-28
CZ91592A3 (en) 1993-04-14
NO304600B1 (no) 1999-01-18
NO921158L (no) 1992-09-28

Similar Documents

Publication Publication Date Title
OA09334A (fr) "Dérivés d'acides aminés".
DK0506463T3 (da) Hidtil ukendte forbindelser betegnet leustroducsiner, deres fremstilling og deres terapeutiske anvendelser
UA32546C2 (uk) 1,2-заміщені 1н-імідазо[4,5-с]хінолін-4-аміни, проміжні сполуки для їх синтезу, антивірусна фармацевтична композиція, спосіб лікування інфікованих ссавців, спосіб індукування біосинтезу інтерферону у ссавців, спосіб уповільнення росту бластом
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
IS5588A (is) Æxliseyðandi miðlar
MX9708611A (es) Compuestos de dialquiltiacumicina.
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
ES2012736A6 (es) Procedimiento para la preparacion de derivados triciclicos de 3-oxopropanonitrilo.
ES2125945T3 (es) Derivados antimicrobianos del carbapenemo, su preparacion y su utilizacion terapeutica.
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
NO953557D0 (no) Antitumorpreparater og fremgangsmåte for deres fremstilling
GR3018581T3 (en) Chemical derivatives of antibiotics LL-E19020 alpha and beta
TH13242EX (th) สารประกอบใหม่ชื่อว่า "เลอุสโทรดัคซิน" การเตรียมและประโยชน์ในการใช้รักษาของสารประกอบเหล่านี้